Advertisement

Topics

Nature’s Sunshine Products Reports Second Quarter 2017 Financial Results

11:50 EDT 8 Aug 2017 | BioMedReports - Blog
  • Second quarter net sales of $81.3 million were down 9.0% year-over-year  
  • Net loss of $0.2 million attributable to common shareholders, or $0.01 per diluted common share during the second quarter
  • Second quarter Adjusted EBITDA of $3.1 million

LEHI, Utah, Aug. 08, 2017 (GLOBE NEWSWIRE)

Read more...

Original Article: Nature’s Sunshine Products Reports Second Quarter 2017 Financial Results

NEXT ARTICLE

More From BioPortfolio on "Nature’s Sunshine Products Reports Second Quarter 2017 Financial Results"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...